HK1209364A1 - Use of actinomyces naeslundii in the treatment or prevention of rheumatoid arthritis or related diseases - Google Patents

Use of actinomyces naeslundii in the treatment or prevention of rheumatoid arthritis or related diseases

Info

Publication number
HK1209364A1
HK1209364A1 HK15110193.7A HK15110193A HK1209364A1 HK 1209364 A1 HK1209364 A1 HK 1209364A1 HK 15110193 A HK15110193 A HK 15110193A HK 1209364 A1 HK1209364 A1 HK 1209364A1
Authority
HK
Hong Kong
Prior art keywords
prevention
treatment
rheumatoid arthritis
related diseases
actinomyces naeslundii
Prior art date
Application number
HK15110193.7A
Other languages
Chinese (zh)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1209364A1 publication Critical patent/HK1209364A1/en

Links

HK15110193.7A 2014-09-30 2015-10-16 Use of actinomyces naeslundii in the treatment or prevention of rheumatoid arthritis or related diseases HK1209364A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410522381.XA CN104546941B (en) 2014-09-30 2014-09-30 Actinomyces naeslundii is treating or preventing the application in rheumatoid arthritis or its related disease

Publications (1)

Publication Number Publication Date
HK1209364A1 true HK1209364A1 (en) 2016-04-01

Family

ID=53064713

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110193.7A HK1209364A1 (en) 2014-09-30 2015-10-16 Use of actinomyces naeslundii in the treatment or prevention of rheumatoid arthritis or related diseases

Country Status (2)

Country Link
CN (1) CN104546941B (en)
HK (1) HK1209364A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105418759B (en) * 2015-12-07 2019-05-21 河南大学 A kind of anti-actinomyces naeslundii Yolk antibody and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268434A (en) * 1979-01-09 1981-05-19 Higerd Thomas B Immunosuppressive extracellular product from oral bacteria
EP1159951A1 (en) * 2000-06-02 2001-12-05 Societe Des Produits Nestle S.A. Use of exogenous lactic bacteria strain against Actinomyces naeslundii-related diseases
CN1152697C (en) * 2000-09-28 2004-06-09 国家医药管理局上海医药工业研究院 Oral cavity bacteriostatic composition containing extract of Chinese herb lotus leaf

Also Published As

Publication number Publication date
CN104546941A (en) 2015-04-29
CN104546941B (en) 2019-01-08

Similar Documents

Publication Publication Date Title
HK1209347A1 (en) Use of bacteroides dorei in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209365A1 (en) Use of bacteroides plebeius in the treatment or prevention of rheumatoid arthritis or related diseases
ZA201608889B (en) Residence structures and related methods
HK1209349A1 (en) Use of parabacteroides merdae in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209360A1 (en) Use of bacteroides ovatus in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209350A1 (en) Use of bacteroides caccae in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209348A1 (en) Use of bacteroides thetaiotaomicron in the treatment or prevention of rheumatoid arthritis or related diseases
ZA201607415B (en) Antibody-drug-conjugate and its use for the treatment of cancer
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
GB201608885D0 (en) Treatment
PL3277280T3 (en) Isomyosmine for use in the treatment of autoimmune diseases
HK1249851A1 (en) Treatment and prevention of the common cold using povidone-iodine
HK1209346A1 (en) Use of bifidobacterium bifidum in the treatment or prevention of rheumatoid arthritis or related diseases
EP3107473A4 (en) Treatment devices and realtime indications
HK1209351A1 (en) Use of haemophilus parainfluenzae in the treatment or prevention of rheumatoid arthritis or related diseases
GB201404372D0 (en) Assay and treatment
HK1209359A1 (en) Use of megamonas hypermegale in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209363A1 (en) Use of lactobacillus crispatus in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209366A1 (en) Use of lactococcus lactis in the treatment or prevention of rheumatoid arthritis or related diseases
HK1246271A1 (en) Method for the synthesis of hydroxy-triglycerides and uses thereof for the prevention and treatment of diseases
HK1209357A1 (en) Use of dialister invisus in the treatment or prevention of rheumatoid arthritis or related diseases
EP3294339A4 (en) Methods and compositions for the treatment of arthritis
HK1209364A1 (en) Use of actinomyces naeslundii in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209369A1 (en) Use of alistipes shahii in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209367A1 (en) Use of clostridium nexile in the treatment or prevention of rheumatoid arthritis or related diseases